Skip to main content
. Author manuscript; available in PMC: 2014 Jul 31.
Published in final edited form as: Am J Med. 2009 Jul;122(7):664–71.e2. doi: 10.1016/j.amjmed.2009.01.026

Table 1.

Sample Population Characteristics (n = 10256)

Mean or Percent Standard Error 95% CI
Age (y) 49.59 1.30 46.97–52.20
Gender (% male) 47.07 0.71 45.64–48.51
Race/ethnicity (%)
 Non-Hispanic white 77.27 2.28 72.69–81.85
 Non-Hispanic black 10.05 1.13 7.79–12.32
 Mexican-American 4.76 0.77 3.21–6.31
 Other 7.92 1.45 4.99–10.84
 Poverty-income ratio 3.17 0.10 2.97–3.37
 Highest grade completed 12.23 0.14 11.93–12.52
Self-reported health status (%)
 Excellent 18.64 0.96 16.70–20.58
 Very good 30.48 1.12 28.23–32.73
 Good 33.43 0.81 31.80–36.05
 Fair 14.03 1.01 12.01–16.05
 Poor 3.37 0.30 2.76–3.97
 eGFR (mL/min) 106.21 1.19 103.82–108.60
Chronic kidney disease (%)
 Stage 1/2 9.66 0.65 8.36–10.97
 Stage 3A 1.80 0.21 1.39–2.22
 Stage 3B-5 1.10 0.14 0.83–1.38
 Diabetes (%) 13.01 0.85 11.30–14.71
 Cancer (%) 4.75 0.45 3.85–5.65
 COPD (%) 8.29 0.44 7.41–9.18
 Liver disease (%) 8.96 0.64 7.67–10.25
 Arthritis (%) 22.84 1.50 19.83–25.85
 25 hydroxy vitamin D concentration, serum (ng/mL) 29.38 0.55 28.27–30.49
 Hemoglobin (g/dL) 14.20 0.04 14.11–14.28
 Bicarbonate, serum (mmol/L) 27.62 0.24 27.15–28.10
 C-reactive protein, serum (units) 0.44 0.01 0.41–0.46
 Hypertensiona (%) 35.06 1.97 31.11–39.01
 Overt cardiovascular diseaseb (%) 12.65 0.92 10.80–14.51

CI = confidence interval; eGFR = estimated glomerular filtration rate; COPD = chronic obstructive pulmonary disease.

a

Joint National Committee 7 guidelines.

b

Composite measure of peripheral arterial disease, coronary artery disease, congestive heart failure, and history of cerebrovascular accident.